Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Cerilliant
Cipla
Chinese Patent Office
Dow
Farmers Insurance
Teva
Julphar
Baxter

Generated: January 22, 2018

DrugPatentWatch Database Preview

Claims for Patent: 5,721,263

« Back to Dashboard

Summary for Patent: 5,721,263
Title: Pharmaceutical composition for angiotensin II-mediated diseases
Abstract:This invention relates to a pharmaceutical composition for angiotensin II-mediated diseases, which comprises a compound having angiotensin II antagonistic activity of the formula ##STR1## wherein R.sup.1 is H or an optionally substituted hydrocarbon residue; R.sup.2 is an optionally esterified carboxyl group; R.sup.3 is a group capable of forming an anion or a group convertible thereinto; X is a covalent bond between the 2 phenyl rings or a spacer having a chain length of 1 to 2 atoms as the linear moiety between the adjoining phenylene group and phenyl group; n is 1 or 2; the ring A is a benzene ring having 1 or 2 optional substituents in addition to R.sup.2 ; and Y is a bond, --O--, --S(O)m-- (wherein m is 0, 1 or 2) or --N(R.sup.4)-- (wherein R.sup.4 is H or an optionally substituted alkyl group), or a pharmaceutically acceptable salt thereof in combination with a compound having diuretic activity or a compound having calcium antagonistic activity.
Inventor(s): Inada; Yoshiyuki (Kawanishi, JP), Kubo; Keiji (Riverside, CA)
Assignee: Takeda Chemical Industries, Ltd. (Osaka, JP)
Application Number:08/351,011
Patent Claims: 1. A pharmaceutical composition, which comprises (.+-.)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7 -carboxylate or a pharmaceutically acceptable salt thereof in combination with manidipine hydrochloride.

2. A pharmaceutical composition, which comprises (.+-.)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7 -carboxylate or a pharmaceutically acceptable salt thereof in combination with hydrochlorothiazide.

3. A pharmaceutical composition, which comprises 2-ethoxy-1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazole-3-yl)biphenyl-4-yl]met hyl]-1H-benzimidazole-7-carboxylic acid or a pharmaceutically acceptable salt thereof in combination with manidipine hydrochloride.

4. A pharmaceutical composition, which comprises 2-ethoxy-1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazole-3-yl)biphenyl-4-yl]met hyl]-1H-benzimidazole-7-carboxylic acid or a pharmaceutically acceptable salt thereof in combination with hydrochiorothiazide.

5. A method for the treatment of hypertension in a mammal in need thereof, which comprises administering to said mammal an effective amount of (.+-.)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7 -carboxylate or a pharmaceutically acceptable salt thereof in combination with an effective amount of manidipine hydrochloride.

6. A method for the treatment of hypertension in a mammal in need thereof which comprises administering to said mammal an effective amount of (.+-.)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7 -caxboxylate or a pharmaceutically acceptable salt thereof in combination with an effective amount of hydrochlorothiazide.

7. A method for the treatment of hypertension in a mammal in need thereof which comprises administering to said mammal an effective amount of 2-ethoxy-1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazole-3-yl)biphenyl-4-yl]met hyl]-1H-benzimidazole-7-carboxylic acid or a pharmaceutically acceptable salt thereof in combination with an effective amount of manidipine hydrochloride.

8. A method for the treatment of hypertension in a mammal in need thereof which comprises administering to said mammal an effective amount of 2-ethoxy-1-[[2'-(2,5-dihydro-5-oxo-1,2,4-oxadiazole-3-yl)biphenyl-4-yl]met hyl]-1H-benzimidazole-7-carboxylic acid or a pharmaceutically acceptable salt thereof in combination with an effective amount of hydrochlorothiazide.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Express Scripts
Julphar
Chinese Patent Office
Chubb
Dow
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot